Page last updated: 2024-10-31

mitoxantrone and Cancer of Endometrium

mitoxantrone has been researched along with Cancer of Endometrium in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Sporadic breast carcinomas demonstrate microsatellite instability, reflecting the presence of DNA mismatch repair-deficient cells, in about one fourth of cases at the time of diagnosis."1.31Resistance to topoisomerase poisons due to loss of DNA mismatch repair. ( Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbel, Y1
Swartzon, M1
Justo, D1
Fedier, A1
Schwarz, VA1
Walt, H1
Carpini, RD1
Haller, U1
Fink, D1

Reviews

1 review available for mitoxantrone and Cancer of Endometrium

ArticleYear
QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Anti-cancer drugs, 2007, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Electrocardiography; Endometrial Neoplasms

2007

Other Studies

1 other study available for mitoxantrone and Cancer of Endometrium

ArticleYear
Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
    International journal of cancer, 2001, Aug-15, Volume: 93, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites,

2001